Abstract

The present invention relates to solid-state forms of Nurandociguat, a soluble guanylate cyclase (sGC) stimulator, including novel crystalline polymorphs, amorphous forms, co-crystals, and solid dispersions. The invention further relates to processes for their preparation, pharmaceutical compositions comprising the same, and their therapeutic use.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

Share

COinS